![]() |
Volumn 12, Issue 2, 2002, Pages 65-70
|
Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MESSENGER RNA;
NEUROTENSIN;
NEUROTENSIN RECEPTOR;
PEPTIDE NUCLEIC ACID;
ANTISENSE OLIGODEOXYNUCLEOTIDE;
NEUROTENSIN TYPE 1 RECEPTOR;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED STUDY;
DISTRIBUTION VOLUME;
DRUG BLOOD LEVEL;
DRUG BRAIN LEVEL;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG LIVER LEVEL;
DRUG TISSUE LEVEL;
HEART;
KIDNEY;
MALE;
NONHUMAN;
PLASMA CLEARANCE;
PRIORITY JOURNAL;
RAT;
SPLEEN;
ANIMAL;
GENETICS;
INTRAVENOUS DRUG ADMINISTRATION;
NUCLEOTIDE SEQUENCE;
SPRAGUE DAWLEY RAT;
TISSUE DISTRIBUTION;
ANIMALIA;
ANIMALS;
BASE SEQUENCE;
INJECTIONS, INTRAVENOUS;
MALE;
OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;
PEPTIDE NUCLEIC ACIDS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, NEUROTENSIN;
RNA, MESSENGER;
TISSUE DISTRIBUTION;
|
EID: 0035989848
PISSN: 10872906
EISSN: None
Source Type: Journal
DOI: 10.1089/108729002760070803 Document Type: Article |
Times cited : (94)
|
References (26)
|